Gerner, Michael Y.

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 2,070

CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

Di Pilato, M., Kfuri-Rubens, R., Pruessmann, J. N., Ozga, A. J., Messemaker, M., Cadilha, B. L., Sivakumar, R., Cianciaruso, C., Warner, R. D., Marangoni, F., et al. (2021) · Cell

Chemokine receptors and signalingCancer Immunotherapy and Biomarkers

Cited by 488

Robust Anti-Viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions

Eickhoff, S., Brewitz, A., Gerner, M. Y., Klauschen, F., Komander, K., Hemmi, H., Garbi, N., Kaisho, T., Germain, R. N., & Kastenmüller, W. (2015) · Cell

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 337

Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity

Fonseca, D. M. D., Hand, T. W., Han, S.-J., Gerner, M. Y., Zaretsky, A. G., Byrd, A. L., Harrison, O. J., Ortiz, A. M., Quinones, M., Trinchieri, G., et al. (2015) · Cell

Gut microbiota and healthImmune Response and Inflammation

Cited by 281